Status Report on the Management of Dermatofibrosarcoma Protuberans: Is There a Viable Role for the Use of Imatinib Mesylate? In Which Cases May It Be Therapeutically Helpful and in Which Cases Not?
Grace K. Kim, DO; James Q. Del Rosso, DO, FAOCD Dr. Kim is from Valley Hospital Medical Center, Las Vegas, Nevada. Dr. Del Rosso is Dermatology Residency Director, Valley Hospital Medical Center, Las Vegas, Nevada. Disclosure: Dr. Kim reports no relevant conflicts of interest. Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, [...]
Brittain H. Tulbert, MD; Clint W. Snyder, PhD; Robert T. Brodell, MD Dr. Tulbert is from Summa Health System, Akron City Hospital, Akron, Ohio. Drs. Snyder and Brodell are from bNortheastern Ohio Universities College of Medicine, Rootstown, Ohio. Dr. Brodell is also from Case Western Reserve University School of Medicine, Cleveland, Ohio, and University of [...]
Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis
Leon H. Kircik, MD; James Q. Del Rosso, DO, FAOCD; Daniel Aversa Dr. Kircik is from Department of Dermatology, Indiana University Medical Center, Indianapolis, Indiana; Department of Dermatology, Mount Sinai Medical Center, New York, New York, DermResearch, PLLC, Louisville, Kentucky. Dr. Del Rosso is from Section of Dermatology ,Valley Hospital Medical Center, Las Vegas, Nevada; [...]
Li Feng, PhD; Stacy Hawkins, PhD Drs. Feng and Hawkins are from Unilever Research & Development, Trumbull, Connecticut
Adam Wiener, DO; Khasha Touloei, OMS3; Bradley P. Glick, DO, MPH, FAOCD Adam Wiener, DO, and Bradley P. Glick, DO, MPH, FAOCD, are from Wellington Regional Medical Center, Wellington, Florida. Khasha Touloei, OMS3, is from Western University of Health Sciences, Pomona, California.